fda compounding glp-1 Hims & Hers stock falls 25% as curtails compounded GLP-1s BREAKING NEWS in the compounding

Many patients describe this as a persistent comfortable fullness or lack of interest in food that differs from typical hunger suppression

The global market hit over $53 billion in 2024, and depending on which analyst report youre reading, projections suggest we could be looking at $165 billion by the early 2030s

requires reconstitution (microsphere suspension)

Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production

After returning to the White House, he revived the plan in an executive order he issued in May, which directed his administration to take various actions to bring drug prices in the U.S